Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Bodurtha

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
International Journal of Cancer|July 15, 1974
Facilitation and inhibition of b16 melanoma by BCG in vivo and by lymphoid cells from bcg-treated mice in vitroD O Chee, A J Bodurtha
Canadian Family Physician Medecin De Famille Canadien|January 29, 2011
Cutaneous malignant melanomaS T Norvell, A J Bodurtha
Canadian Journal of Surgery. Journal Canadien De Chirurgie|January 1, 1983
Isolation-perfusion: a valuable alternative in managing locally recurrent and in-transit melanomaS T Norvell, A J Bodurtha
Canadian Journal of Surgery. Journal Canadien De Chirurgie|September 1, 1980
Analysis of 29 cases of pancreatic pseudocyst treated surgicallyA J Bodurtha, H Dajee, C K You
Investigational New Drugs|February 1, 1990
Phase II study of trimetrexate in malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group studyN A Iscoe, E A Eisenhauer, A J Bodurtha
Journal of the Reticuloendothelial Society|December 1, 1974
Bacillus Calmette-Guerin in the treatment of neoplastic diseaseJ F Laucius, A J Bodurtha, M J Mastrangelo, et al.
Cancer|November 1, 1977
A Phase II study of autologous irradiated tumor cells plus BCG in patients with metastatic malignant melanomaJ F Laucius, A J Bodurtha, J M Mastrangelo, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|September 1, 1977
Prophylactic node dissection for malignant melanomaS T Norvell, J J McCleave, A J Bodurtha, et al.
Cancer Treatment Reports|May 1, 1976
Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine (NSC-67574) in the treatment of metastatic malignant melanomaR E Bellett, M J Mastrangelo, J F Laucius, et al.
International Journal of Cancer|October 15, 1975
Sequential in vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donorsJ Berkelhammer, M J Mastrangelo, J F Laucius, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
International Journal of Cancer|July 15, 1974
Facilitation and inhibition of b16 melanoma by BCG in vivo and by lymphoid cells from bcg-treated mice in vitroD O Chee, A J Bodurtha
Canadian Family Physician Medecin De Famille Canadien|January 29, 2011
Cutaneous malignant melanomaS T Norvell, A J Bodurtha
Canadian Journal of Surgery. Journal Canadien De Chirurgie|January 1, 1983
Isolation-perfusion: a valuable alternative in managing locally recurrent and in-transit melanomaS T Norvell, A J Bodurtha
Canadian Journal of Surgery. Journal Canadien De Chirurgie|September 1, 1980
Analysis of 29 cases of pancreatic pseudocyst treated surgicallyA J Bodurtha, H Dajee, C K You
Investigational New Drugs|February 1, 1990
Phase II study of trimetrexate in malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group studyN A Iscoe, E A Eisenhauer, A J Bodurtha
Journal of the Reticuloendothelial Society|December 1, 1974
Bacillus Calmette-Guerin in the treatment of neoplastic diseaseJ F Laucius, A J Bodurtha, M J Mastrangelo, et al.
Cancer|November 1, 1977
A Phase II study of autologous irradiated tumor cells plus BCG in patients with metastatic malignant melanomaJ F Laucius, A J Bodurtha, J M Mastrangelo, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|September 1, 1977
Prophylactic node dissection for malignant melanomaS T Norvell, J J McCleave, A J Bodurtha, et al.
Cancer Treatment Reports|May 1, 1976
Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine (NSC-67574) in the treatment of metastatic malignant melanomaR E Bellett, M J Mastrangelo, J F Laucius, et al.
International Journal of Cancer|October 15, 1975
Sequential in vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donorsJ Berkelhammer, M J Mastrangelo, J F Laucius, et al.
Pageof 2